<DOC>
	<DOCNO>NCT01459484</DOCNO>
	<brief_summary>The main objective study assess survival patient non metastatic osteosarcoma extremity treat different chemotherapy protocol , accord expression ABCB1/P-glycoprotein</brief_summary>
	<brief_title>ABCB1/P-glycoprotein Expression Biologic Stratification Factor Patients With Non Metastatic Osteosarcoma</brief_title>
	<detailed_description>The Primary objective : * Overall survival patient non metastatic osteosarcoma extremity treat different chemotherapy approach ( 5 drug vs 3 drug ) , accord expression ABCB1/P-glycoprotein The Secondary objective : - ass survival patient express ABCB1/P-glycoprotein , chemotherapy protocol base 5 available active drug ( Methotrexate , cisplatinum , doxorubicine , ifosfamide mifamurtide ) - ass survival patient express ABCB1/P-glycoprotein</detailed_description>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Mifamurtide</mesh_term>
	<mesh_term>Acetylmuramyl-Alanyl-Isoglutamine</mesh_term>
	<criteria>Histology confirm diagnosis extremity high grade osteosarcoma Age â‰¤ 40 year Localized disease presence skip metastasis Hepatic , renal bone marrow normal function LVEF &gt; 50 % No previous surgery and/ chemotheraputic osteosarcoma treatment , No 4 week interval histological diagnosis start chemotherapy Informed consent study participation obtain . Presence metastases skip metastasis Periosteal Osteosarcoma , parostal osteosarcoma , secondary osteosarcoma , Medical contraindication drug foreseen protocol , Subject pregnant breast feeding Mental social condition compromise correct adherence protocol procedure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Non metastatic extremity high grade osteosarcoma</keyword>
</DOC>